Clinical Trials List
2022-11-01 - 2025-04-14
Phase III
Not yet recruiting8
ICD-10J84.01
Alveolar proteinosis
ICD-9516.0
Pulmonary alveolar proteinosis
-
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Yi-Hsing Chen Division of Rheumatology
- 曾智偉 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 廖育婉 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 林明泰 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 張竣期 未分科
- 林聖皓 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 施柏丞 Division of Rheumatology
- 林俊維 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 蕭凱鴻 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Wei-An Chang Division of Thoracic Medicine
- Ming-Ju Tsai Division of Thoracic Medicine
- Hung-Ling Huang Division of Thoracic Medicine
- 鄭孟軒 Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- 陳家閔 Division of Thoracic Medicine
- Jui-Sheng Hsu 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chin-Wei Kuo 未分科
- Chian-Wei Chen 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 曹彥博 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
Co-Principal Investigator
- KO-JEN LI 未分科
- CHIEH-YU SHEN 未分科
- HAO-CHIEN WANG 未分科
- 黃昱森 未分科
- 呂政勳 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
1041 participants
